Cemiplimab, a human monoclonal anti-PD-1, in patients (pts) with advanced or metastatic hepatocellular carcinoma (HCC): Data from an expansion cohort (EC) in a phase I study
Titel:
Cemiplimab, a human monoclonal anti-PD-1, in patients (pts) with advanced or metastatic hepatocellular carcinoma (HCC): Data from an expansion cohort (EC) in a phase I study
Auteur:
He, A.R. Weiss, G.J. Falchook, G. Yee, N.S. Gil-Martin, M. Shahda, S. Moreno, V. Brana, I. Crittenden, M. Formenti, S. Al-Rajabi, R. Papadopoulos, K.P. Pishvaian, M.J. Stankevich, E. Feng, M. Li, J. Mathias, M. Kroog, G. Lowy, I. Fury, M.G.